What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study

Collaborators, Affiliations

International Neoadjuvant Kidney Cancer Consortium (INKCC) members:
Jason Abel, Laurence Albiges, Jens Bedke, Karim Bensalah, Stephanie A Berg, Jean Christophe Bernhard, Axel Bex, James P Blackmur, Gennady Bratslavsky, David A Braun, Janet Brown, Lisa Browning, James Brugarolas, Femke Burgers, Riccardo Campi, Umberto Capitanio, Toni K Choueiri, Antonio Finelli, Andrew Furness, Ferdia A Gallagher, Daniel George, Niels Graafland, John Haanen, Naomi B Haas, Ari Hakimi, Hans Hammers, Michelle S Hirsch, William H J Ince, Eric Jonasch, James O Jones, Payal Kapur, Alex Laird, Bryan Lewis, Marston Linehan, Viraj Master, Bradley McGregor, Rana R McKay, Rohit Mehra, Arnaud Mejean, Tom Mitchell, Robert Motzer, David Nicol, Grenville Oades, Brent O'Carrigan, Sumanta Pal, Phillip Pierorazio, Susan Poteat, Andrew Protheroe, Priya Rao, Kimryn Rathmell, Brian Rini, Sabrina H Rossi, Antonio Rullan, Daniel Shapiro, Scott Shepherd, Sabina Signoretti, Eric A Singer, Shankar Siva, Grant D Stewart, Chuck Stravin, Christina Suarez, Mark Sullivan, Nizar Tannir, Zayd Tippu, Samra Turajlic, Mark Tuthill, Robert Uzzo, J C Koen van der Mijn, Maurits L van Montfoort, Ulka Vaishampayan, Balaji Venugopal, Martin Voss, Christof Vulsteke, Tom Waddell, Anne Y Warren, James Wason, Vincent Xu

¹ Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
² Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, USA.
³ Department of Surgery and Surgical Oncology (Urology), Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada; International Kidney Cancer Coalition, Utrecht, The Netherlands.
⁴ Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
⁵ Department of Urology, Western General Hospital, Edinburgh, UK; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
⁶ KidneyCAN, Philadelphia, USA.
⁷ Francis Crick Institute, London, UK.
⁸ Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁹ Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Surgery and Interventional Science, Royal Free London NHS Foundation Trust, University College London, London, UK.
¹⁰ Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: gds35@cam.ac.uk.

S H Rossi et al. Ann Oncol. 2025.

. 2025 Jun 4:S0923-7534(25)00769-0.

doi: 10.1016/j.annonc.2025.05.540. Online ahead of print.

International Neoadjuvant Kidney Cancer Consortium (INKCC) members:
Jason Abel, Laurence Albiges, Jens Bedke, Karim Bensalah, Stephanie A Berg, Jean Christophe Bernhard, Axel Bex, James P Blackmur, Gennady Bratslavsky, David A Braun, Janet Brown, Lisa Browning, James Brugarolas, Femke Burgers, Riccardo Campi, Umberto Capitanio, Toni K Choueiri, Antonio Finelli, Andrew Furness, Ferdia A Gallagher, Daniel George, Niels Graafland, John Haanen, Naomi B Haas, Ari Hakimi, Hans Hammers, Michelle S Hirsch, William H J Ince, Eric Jonasch, James O Jones, Payal Kapur, Alex Laird, Bryan Lewis, Marston Linehan, Viraj Master, Bradley McGregor, Rana R McKay, Rohit Mehra, Arnaud Mejean, Tom Mitchell, Robert Motzer, David Nicol, Grenville Oades, Brent O'Carrigan, Sumanta Pal, Phillip Pierorazio, Susan Poteat, Andrew Protheroe, Priya Rao, Kimryn Rathmell, Brian Rini, Sabrina H Rossi, Antonio Rullan, Daniel Shapiro, Scott Shepherd, Sabina Signoretti, Eric A Singer, Shankar Siva, Grant D Stewart, Chuck Stravin, Christina Suarez, Mark Sullivan, Nizar Tannir, Zayd Tippu, Samra Turajlic, Mark Tuthill, Robert Uzzo, J C Koen van der Mijn, Maurits L van Montfoort, Ulka Vaishampayan, Balaji Venugopal, Martin Voss, Christof Vulsteke, Tom Waddell, Anne Y Warren, James Wason, Vincent Xu

¹ Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
² Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, USA.
³ Department of Surgery and Surgical Oncology (Urology), Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada; International Kidney Cancer Coalition, Utrecht, The Netherlands.
⁴ Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
⁵ Department of Urology, Western General Hospital, Edinburgh, UK; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
⁶ KidneyCAN, Philadelphia, USA.
⁷ Francis Crick Institute, London, UK.
⁸ Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁹ Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Surgery and Interventional Science, Royal Free London NHS Foundation Trust, University College London, London, UK.
¹⁰ Department of Surgery, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: gds35@cam.ac.uk.

No abstract available

Publication types